These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29395629)

  • 41. Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy.
    Nouhaud E; Créhange G; Cueff A; Quivrin M; Rouffiac-Thouant M; Mineur L; Garcia R; Chamois J; Maingon P
    BMC Res Notes; 2013 Nov; 6():492. PubMed ID: 24279802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel strategy in the treatment of liver metastases - Hepatic resection combined with stereotactic body radiotherapy.
    Ihnát P; Skácelíková E; Vávra P; Jonszta T; Ihnát Rudinská L; Tomášková H
    Asian J Surg; 2020 Sep; 43(9):902-906. PubMed ID: 31911035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
    Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
    J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic body radiation therapy for colorectal liver metastases.
    van der Pool AE; Méndez Romero A; Wunderink W; Heijmen BJ; Levendag PC; Verhoef C; Ijzermans JN
    Br J Surg; 2010 Mar; 97(3):377-82. PubMed ID: 20095016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
    Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
    J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
    Berkovic P; Gulyban A; Nguyen PV; Dechambre D; Martinive P; Jansen N; Lakosi F; Janvary L; Coucke PA
    Clin Colorectal Cancer; 2017 Dec; 16(4):349-357.e1. PubMed ID: 28462852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience.
    Alsuhaibani A; Elashwah A; Alkafi A; Constantinescus C; ALzorkany F
    J Gastrointest Cancer; 2019 Dec; 50(4):879-887. PubMed ID: 30291546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases.
    Yu J; Kim DH; Lee J; Shin YM; Kim JH; Yoon SM; Jung J; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim SY; Kim JE; Park JH; Kim SY
    Cancer Res Treat; 2022 Jul; 54(3):850-859. PubMed ID: 34645129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
    Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
    Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases.
    Swaminath A; Massey C; Brierley JD; Dinniwell R; Wong R; Kim JJ; Velec M; Brock KK; Dawson LA
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):639-48. PubMed ID: 26461006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
    Hearn JW; Videtic GM; Djemil T; Stephans KL
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors.
    Kress MA; Collins BT; Collins SP; Dritschilo A; Gagnon G; Unger K
    Radiat Oncol; 2012 Sep; 7():148. PubMed ID: 22950606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer.
    Kim MS; Kang JK; Cho CK; Choi CW; Seo YS; Hwang DY; Moon SM; Kang HJ; Kim YH; Kim MS; Oh N
    Tumori; 2009; 95(4):449-54. PubMed ID: 19856655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendations.
    Agarwal JP; Pilar A; Mummudi N; Gupta M; Laskar SG; Pathak RS; Tibdewal AR; Kinhikar R; Ghadi Y; Tandon S; Purandare N; Prabhash K; Patil V
    Indian J Cancer; 2020; 57(1):18-24. PubMed ID: 31929233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
    Robin TP; Raben D; Schefter TE
    Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
    Milano MT; Katz AW; Zhang H; Okunieff P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic radiotherapy of primary liver cancer and hepatic metastases.
    Wulf J; Guckenberger M; Haedinger U; Oppitz U; Mueller G; Baier K; Flentje M
    Acta Oncol; 2006; 45(7):838-47. PubMed ID: 16982548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.